Company

Veracyte Inc.

Veracyte develops genomic diagnostics for thyroid and non-small cell lung cancer.

About

Founded in 2008, Veracyte develops genomic diagnostics for thyroid and non-small cell lung cancer. Formerly known as Calderome Inc., the company is based in South San Francisco, US.

6Funding rounds

8Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in